Skip to content
Boston Collaborative Drug Surveillance Program (BCDSP)
  • Home
  • Services
  • Research
  • Our Team
  • History
  • Publications

Ophthalmology

  • Home
  • Ophthalmology

Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis

Posted by By BCDSP May 29, 2017Posted inUncategorized
Journal: Ophthalmology Authors: Claudia Becker 1, Susan S Jick 2, Christoph R Meier 3 NLM Citation: Becker C, Jick SS, Meier CR. Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis. Ophthalmology. 2017 Nov;124(11):1635-1639.…
Read More
  • @BCDSP_DRG on Twitter
  • BCDSP on LinkedIn
  • @bcdsp.bsky.social‬ on BlueSky
Boston Collaborative Drug Surveillance Program (BCDSP)

55 Waltham Street, Rear | Lexington, MA 02421 USA
Phone: +1 (781) 862-6660
E-mail: info@bcdsp.org

Copyright 2026 — Boston Collaborative Drug Surveillance Program (BCDSP). All rights reserved.
Scroll to Top